APIs and intermediates. Italy’s Ribbon is an FDA- and EU-certifi ed Italy’s Indena is a producer of botanical-origin APIs and a large
leading manufacturer and supplier of beta-lactam antibiotics for manufacturer of natural and semi-synthetic paclitaxel. Indena’s
the pharmaceutical and veterinary industries, in oral and sterile
activity is supported by dedicated research, development and
grades. Since 2008 Ribbon has been owned by Fresenius Kabi.
analytical labs.
Germany-based Sabinsa Europe manufactures more than 20
Flavine Europe of Germany has provided its customers with
synthetic intermediates used in the pharmaceutical and nutritional
marketing, distribution and regulatory affairs services since 1975.
industries, 20 nutritional fi ne chemicals and more than 50
Teams from the US, Germany, Austria, China and India will be on
standardised herbal extracts and herb powders. Sabinsa also
hand to discuss APIs and intermediates, as well as licensing and
provides custom manufacturing from lab to pilot/semi-commercial
manufacturing opportunities.
scales, as well as process development. Shanghai, China-based
Alapis of Athens, Greece, plans to unveil 11 new generic and “super
Saniver will be able to talk visitors through its strengths in various
generic” developments including new galenical forms of three APIs.
pharmaceutical bulk drugs and extract products.
Adamed is a Polish company focusing on cardiology, CNS,
Selectchemie is an independent provider of pharmaceutical gynaecology, pulmonology, gastroenterology and ophthalmology.
raw materials (mainly APIs and excipients), serving more than The fi rm invests in research for innovative solutions. Laboratoires
75 countries. Components for human and animal nutrition are
Genopharm of France is part of the international ALKO Group
distributed in parts of Europe. The group has branches in Brazil,
focused on the supply of speciality medicines for 65 countries, as
Italy and France.
well as APIs and contract manufacturing.
Shenzhen Techdow Pharmaceutical is a Chinese LMWH
Nutra Specialities India is a GMP-compliant company focused
manufacturer. The fi rm’s enoxaparin has passed inspections from
on the wellbeing and healthcare industries. Jesalis Pharma
the Australian TGA. Its products include enoxaparin sodium,
of Germany will be on hand to discuss its API business and
dalteparin sodium, nadroparin calcium and injections. China’s
development services.
API fi rm Ningbo United Group focuses on valsartan, ramipril,
Merck Chemicals is a supplier to the biopharmaceutical industry;
atorvastatin Ca, losartan, candesartan cilexetil and venlafaxine. its portfolio includes the resins Fractogel and Eshmuno for purifying
In addition, it offers intermediates of ezetimibe, losartan, ramipril biomolecules, and Emprove bio quality products and solutions for
and perindopril. challenges in upstream, downstream and formulation.
7
HOSPITAL / SPECIALTY PRODUCTS
®
specialty products  innovative solutions
Your Canadian Specialty
Pharmaceutical Partner
Looking to expand into Canada?
Methapharm offers sales and marketing, regulatory
services, market access programs, and GMP
distribution capabilities for product partnership
opportunities in Canada.
Licensed to distribute pharmaceutical products and
medical devices, Methapharm may be your ideal
partner to build and manage your brand in Canada.
Please visit us at our stand 3D07 at CPhI Madrid.
We look forward to working with you.
Methapharm Inc. Tel: (+1) 519.751.3602
81 Sinclair Boulevard

Fax: (+1) 519.751.9149
Brantford, Ontario www.methapharm.com
N3S 7X6 Canada bd@methapharm.com
Scrip World Pharmaceutical News Supplement August 2009
cphi.com | icsexpo.com | p-mec.com | bioph-online.com
wherepharmameets.com | scripnews.com
Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44